Interaction between stromal cells and tumor cells induces chemoresistance and matrix metalloproteinase secretion

Annals of the New York Academy of Sciences

Volumn 878, Issue , 1999, Pages 642-646

  Zhu, Baoqian ^a   Block, Norman L ^a   Lokeshwar, Bal L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MATRIX METALLOPROTEINASE; PACLITAXEL; TETRACYCLINE DERIVATIVE;

CANCER CELL; CANCER CELL CULTURE; CELL INTERACTION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG RESISTANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MALE; PROSTATE CANCER; STROMA CELL;

EID: 0032838954     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07750.x     Document Type: Conference Paper

References (13)

1. 1. Ismail, M. & L.G. Gomella. 1997. Current treatment of advanced prostate cancer. Tech. Urol. 3(1): 16-24.
2. 2. Raghavan, D., B. Koczwara & M. Javle. 1997. Evolving strategies of cytotoxic chemotherapy for advanced prostate cancer. Eur. J. Cancer 33(4): 566-574.
3. 3. Dong, Z., R. Radinsky, D. Fan et al. 1994. Organ-specific modulation of steady state mdr gene expression and drug resistance in murine colon cancer cells. J. Natl. Cancer Inst. 86: 913-920.
4. 4. Gleave, M., J.T. Hsieh, C. Gao et al. 1991. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res. 51: 3753-3761.
5. 5. Passaniti, A., J.T. Isaacs, J.A. Haney et al. 1992. Stimulation of human prostatic carcinoma tumor growth in athymic mice and control of migration in culture by extracellular matrix. Int. J. Cancer 51: 318-324.
6. 6. Hayward, S.W., M.A. Rosen & G.R. Cunha. 1997. Stromal-epithelial interactions in the normal and neoplastic prostate. Brit. J. Urol. 79 (Suppl 2): 18-26.
7. 7. Heppner, K.J., L.M. Matrisian, R.A. Jensen et al. 1997. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am. J. Pathol. 149(1): 273-282.
8. 8. Donnelli, M.G., R. Russo & S. Garrattinin. 1975. Selective chemotherapy in relation to the site of tumor transplantation. Int. J. Cancer 32: 78-86.
9. 9. Teicher, B.A., T.S. Herman, S.A. Holden et al. 1990. Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. Science 247: 1457-1461.
10. 10. Van Den Bogert, C., B.H.J. Dontje, M. Holtrop et al. 1986. Arrest of the proliferation of renal and prostate carcinomas of human origin by inhibition of mitochondrial protein synthesis. Cancer Res. 46: 3283-3289.
11. 11. Sipos, E.P., R.J. Tamargo, J.D. Weingart & H. Brem. 1994. Inhibition of tumor angiogenesis. Ann. N.Y. Acad. Sci. 732: 263-272.
12. 12. Lokeshwar, B.L., H.L. Houston-Clark, M.G. Selzer et al. 1998. Potential application of achemically modified non-antimicrobial tetracycline (CMT-3) against metastatic prostate cancer. Adv. Dent. Res. 12: 97-102.
13. 13. Mizuguchi, H., N. Utoguchi & T. Mayumi. 1997. Preparation of glial extracellular matrix: a novel method to analyze glial-endothelial cell interaction. Brain Res. Protocols 1: 339-343.